Nika Pharmaceuticals reported asset growth of 0.00% for the quarter ended Dec 2023. These growth metrics cover 11 quarters of results from Jun 2021 through Dec 2023, standardized by Business Quant from the company’s SEC filings.
| Growth MetricsGrowth | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||
| Total Debt (QoQ) | 127.42% | 83.20% | 13.20% | -78.80% | |||||||
| Total Debt Growth (1y) | 0.00% | ||||||||||
| Return on Equity [ROE] (QoQ)ROE (QoQ) | -19.95M | ||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -6.77M | 2.25M | -8.17M | 1.26M | 11.92M | 0.02M | |||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -11.42M | 7.27M | 5.04M | ||||||||
| Operating Income (QoQ)Op. Inc (QoQ) | 48.57% | 8.79% | -22.27% | 291.39% | -50,068.49% | 99.80% | -137.42% | 230.03% | -242.08% | 63.52% | |
| Operating Income Growth (1y)Op. Inc Growth (1y) | 209.77% | -106,557.99% | -134.86% | -356.06% | 209.85% | 99.12% | -60.01% | ||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | -48.57% | -8.79% | -1,067.91% | 75.82% | -49,868.49% | 99.80% | -137.42% | -30.03% | -42.08% | 63.52% | |
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | -209.77% | -106,757.99% | -334.86% | 42.39% | -209.85% | 99.12% | -60.01% | ||||
| Net Income (QoQ) | -48.57% | -8.79% | 22.27% | 91.39% | 3,953.36% | -102.48% | 100,311.07% | -99.69% | -442.08% | 84.85% | |
| Net Income Growth (1y) | 9.77% | 8,551.91% | -334.86% | 192,396.36% | 209.85% | -126.15% | -60.01% | ||||
| Net Cash Flow (QoQ)NCF (QoQ) | -277.56% | 235.66% | 2,061.72% | -101.12% | 9,629.75% | -63.32% | 144.86% | -86.71% | 2,719.08% | -80.12% | |
| Net Cash Flow Growth (1y)NCF Growth (1y) | -24.41% | 3,240.15% | 749.12% | -3.82% | 1,237.66% | 236.54% | 82.34% | ||||
| Income After Tax (QoQ) | 151.43% | -8.79% | -1,067.91% | 124.18% | -50,068.49% | 99.80% | -137.42% | -30.03% | -42.08% | 63.52% | |
| Income After Tax Growth (1y) | 209.77% | -106,757.99% | -334.86% | 42.39% | -409.85% | 99.12% | -60.01% | ||||
| Free Cash Flow (QoQ)FCF (QoQ) | 48.57% | 8.79% | 1,067.91% | -124.18% | 371.41% | -54.27% | 91.99% | -230.03% | 442.08% | -84.85% | |
| Free Cash Flow Growth (1y)FCF Growth (1y) | -9.77% | 679.32% | 390.44% | -42.39% | -209.85% | 290.54% | 29.39% | ||||
| EPS (Diluted) (QoQ) | -98.29% | -8.79% | -1,067.91% | -625.31% | -790.82% | 99.80% | -142.88% | -7.45% | -42.08% | 63.52% | |
| EPS (Diluted) Growth (1y) | -209.77% | -57,143.51% | -225.61% | 68.48% | 95.33% | 99.26% | -35.26% | ||||
| EPS (Basic) (QoQ) | -98.29% | -8.79% | -1,067.91% | 75.82% | -26,624.47% | 99.80% | -142.88% | -7.45% | -42.08% | 63.52% | |
| EPS (Basic) Growth (1y) | -103.66% | -57,143.51% | -225.61% | 68.48% | -40.09% | 99.26% | -35.26% | ||||
| EBT (QoQ) | 151.43% | -8.79% | -1,067.91% | 124.18% | -50,068.49% | 99.80% | -137.42% | -30.03% | -42.08% | 63.52% | |
| EBT Growth (1y) | 209.77% | -106,757.99% | -334.86% | 42.39% | -409.85% | 99.12% | -60.01% | ||||
| EBIT (QoQ) | 48.57% | 8.79% | -22.27% | 291.39% | -50,068.49% | 99.80% | -137.42% | 230.03% | -242.08% | 63.52% | |
| EBIT Growth (1y) | 209.77% | -106,557.99% | -134.86% | -356.06% | 209.85% | 99.12% | -60.01% | ||||
| Cash from Operations (QoQ)Cash from Ops. (QoQ) | 48.57% | 8.79% | 1,067.91% | -124.18% | 371.41% | -54.27% | 91.99% | -230.03% | 442.08% | -84.85% | |
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | -9.77% | 679.32% | 390.44% | -42.39% | -209.85% | 290.54% | 29.39% | ||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -76.52% | -79.20% | 10,195.18% | -54.20% | -77.93% | 416.09% | 147.88% | -1.29% | -92.08% | ||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -93.88% | 130.37% | 116.54% | 5,272.29% | 29.35% | 178.74% | 0.00% | ||||
| Assets (QoQ) | -79.20% | 10,195.18% | -54.20% | -77.93% | 416.09% | 147.88% | -1.29% | -92.08% | |||
| Assets Growth (1y) | 116.54% | 5,272.29% | 29.35% | 178.74% | 0.00% |
Pull Nika Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NIKA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NIKA", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NIKA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();